Coherus Oncology (CHRS) Cash from Investing Activities Growth (1y) (2014 - 2026)
Coherus Oncology (CHRS) Cash from Investing Activities Growth (1y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 62.68% |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | -674.01% |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -166.24% |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Coherus Oncology | 200.42 Mn | 33.38 Mn | 8.50 Mn | 275.31% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 275.31% |
| Dec 31, 2025 | -423.62% |
| Sep 30, 2025 | -15,241.22% |
| Jun 30, 2025 | 1,572.83% |
| Mar 31, 2025 | -108.62% |
| Dec 31, 2024 | -101.54% |
| Sep 30, 2024 | -99.12% |
| Jun 30, 2024 | -33.14% |
| Mar 31, 2024 | 1,056.93% |
| Dec 31, 2023 | 127.10% |
| Sep 30, 2023 | 11,160.39% |
| Jun 30, 2023 | 4,800.57% |
| Mar 31, 2023 | 149.21% |
| Dec 31, 2022 | -220.85% |
| Sep 30, 2022 | -102.86% |
| Jun 30, 2022 | -103.73% |
| Mar 31, 2022 | 87.52% |
| Dec 31, 2021 | -48.83% |
| Sep 30, 2021 | -2.54% |
| Jun 30, 2021 | 109.86% |